Stelara (ustekinumab) is a biologic therapy that targets interleukin-12 and interleukin-23 (IL-12/23), proteins involved in inflammatory joint and skin conditions. At Scottsdale Rheumatology Center, our physicians manage Stelara therapy, including IV induction infusions administered in our in-house infusion suite for eligible patients.
Stelara is commonly prescribed for:
Depending on your condition, Stelara treatment may begin with a weight-based IV induction infusion, administered by our specially trained infusion nurses, followed by maintenance dosing. Our physicians determine the right treatment plan and monitor your progress over time.
Before starting Stelara, our physicians review your medical history, including screening for infections such as tuberculosis. Ongoing monitoring helps our team track your response and watch for any concerns. Discuss the full risks and benefits of Stelara with your physician.
Our office can help coordinate prior authorization for Stelara therapy with most major insurance plans. Visit our Health Insurance page for more information.
For certain conditions, Stelara treatment begins with a weight-based IV induction infusion before transitioning to maintenance dosing.
What does Stelara treat?Stelara is used for psoriatic arthritis, plaque psoriasis, Crohn's disease, and ulcerative colitis.
How often is Stelara maintenance dosing given?After induction, maintenance dosing is typically given every 8 to 12 weeks, as determined by your physician.
Book an appointment to discuss Stelara therapy with Scottsdale Rheumatology Center.
Related: Psoriatic Arthritis | Infusion Suite
